177A · Kohjin Bio Co., Ltd. · Financials
Market Cap
3.54B JPY
Shares
5.11M
Volume · Nov 10
800
Avg daily vol (3M)
3070
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
4.94B
-5.1%
FY2026
Net Income
251.02M
-68.4%
FY2026
Gross Margin
37.6%
-7.8pp
FY2026
Operating Margin
6.92%
-12.1pp
FY2026
Operating Cash Flow
698.51M
-23.7%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| JPY | 4.94B | 5.21B | 4.77B |
| JPY | 3.08B | 2.84B | 2.89B |
| JPY | 1.86B | 2.37B | 1.88B |
| JPY | 341.54M | 991.14M | 596.82M |
| JPY | 332.26M | 1.02B | 635.6M |
| JPY | 81.24M | 220.54M | 250.62M |
| JPY | 251.02M | 794.76M | 384.98M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 259.99M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.